Electromed, Inc.
HealthcareAMEX:ELMD · New York Stock Exchange American
-$0.47 today
Vol 0.03M · Avg 0.05M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
17.4%
avg 10.4%
ROIC
16.7%
avg 10.0%
ROA
14.0%
avg 8.7%
Analysis
ROE is currently the strongest return metric at 17.4% versus its period average of 10.4%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
James L. Cunniff | President, Chief Executive Officer & Director | $939,031.00 | — | 60 | $148,777.00 | 1.80% |
Bradley Nagel | Chief Financial Officer, Treasurer & Secretary | $547,336.00 | — | 44 | $31,439.00 | 0.38% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
14
$3.80M
Net Sentiment
$3.80M
Net selling
Most Active
Summers Andrew
5 transactions
1–10 of 14
Analysis
Insiders reported 0 buys worth $0.00 and 14 sells worth $3.80M over the last 12 months. That adds up to net selling of $3.80M. Summers Andrew was the most active insider with 5 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +86.6% | +15.6% (15yr)1 analysts |
| Revenue | N/A | N/A | -0.2% | +10.4% (15yr)1 analysts |
| Net Income | N/A | N/A | +80.2% | +15.9% (15yr)1 analysts |
| EBIT | N/A | N/A | +29.3% | +20.1% (15yr)1 analysts |
Analysis
Recent growth has been strongest in EPS at +86.6% over three years. Forward estimates point to EBIT at +20.1% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
Perspective Therapeutics, Inc.
AMEX:CATX
$227.89M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
InfuSystem Holdings, Inc.
AMEX:INFU
$184.46M
Inogen, Inc.
NASDAQ:INGN
$173.28M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
MaxCyte, Inc.
NASDAQ:MXCT
$119.98M
Solana Company
NASDAQ:HSDT
$89.92M
Outset Medical, Inc.
NASDAQ:OM
$83.23M
Who manages ELMD?
Electromed, Inc. (ELMD) lists 2 active executives. The top listed executive is James L. Cunniff, President, Chief Executive Officer & Director.
Are ELMD insiders buying or selling?
Recent insider activity shows net selling of $13.67M.
Explore More
Continue the stock analysis
Jump to another research area for this company.